These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4198303)

  • 21. Hypercalcemia without EEG abnormalities.
    Etheridge JE; Grabow JD
    Dis Nerv Syst; 1971 Jul; 32(7):479-83. PubMed ID: 5570416
    [No Abstract]   [Full Text] [Related]  

  • 22. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of hydergine on the functional manifestations of encephalic vasomotricity].
    Memin Y; Rigal P
    Lyon Med; 1971 Jun; 225(11):1177-82. PubMed ID: 4997290
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 25. [New possibilities in the management of venous perfusion disorders].
    Weitgasser H
    Z Haut Geschlechtskr; 1968 Feb; 43(4):153-8. PubMed ID: 4969940
    [No Abstract]   [Full Text] [Related]  

  • 26. [Geriatric pharmacotherapy of the neurasthenic syndrome (an experimental psychological and clinical long term study)].
    Schnell R; Oswald WD
    Arztl Forsch; 1967 Dec; 21(12):464-70. PubMed ID: 4970409
    [No Abstract]   [Full Text] [Related]  

  • 27. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 28. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 30. [Somatic initial symptoms of schizophrenia. A retrospective study].
    Smith PS
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(2):379-417. PubMed ID: 5265225
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of elderly patients with an effective anxiolytic drug combination].
    Hadjwasiri H
    Schweiz Rundsch Med Prax; 1973 Nov; 62(44):1383-9. PubMed ID: 4202443
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hydergine in the treatment of chronic psychoses].
    Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P
    Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fatigue and tensional labilities].
    Blanc P
    Schweiz Rundsch Med Prax; 1970 Nov; 59(47):1654-60. PubMed ID: 4997753
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of treatment with SEN DCS-1. Preliminary note on 24 patients].
    Pastor Franco A
    Rev Clin Esp; 1970 Aug; 118(4):359-64. PubMed ID: 4991986
    [No Abstract]   [Full Text] [Related]  

  • 35. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
    Kaye C
    Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of circulatory venous diseases: double-blind study with Sandovene].
    Lambelet F
    Schweiz Rundsch Med Prax; 1973 Jul; 62(29):925-9. PubMed ID: 4198273
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic effects of hydergine in mental disorders in the involutional age].
    Bonasera N; Smorto M; Scialfa G
    Osp Psichiatr; 1968; 36(1):75-87. PubMed ID: 4988290
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 39. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical effects of the DHR-1015 compound in the treatment of arterial hypertension].
    Sáez Causillas A
    Rev Clin Esp; 1968 Oct; 111(2):191-8. PubMed ID: 4980458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.